About KDDF
R&D Pipeline
R&D Commercialization Initiatives
Media Room
Contact Us
KOR
ENG
About KDDF
Greetings
Who We Are
Networks
R&D Pipeline
Pipeline (2021-2030)
Previous Pipeline (2011-2020)
R&D Commercialization Initiatives
Media Room
Photo & Video
Publications
News
Contact Us
R&D Pipeline
R&D Pipeline
Pipeline (2021-2030)
Pipeline (2021-2030)
Previous Pipeline (2011-2020)
Pipeline (2021-2030)
Cardiovascular - rProtein (1)
Modality
Indication
Targets
Stage
Company
Project No.
Detail
1
Nonclinical Development of PP1 Targeting Drug for Pulmonary Arterial Hypertension
rProtein
Pulmonary hypertension
PP1
Preclinical
NadianBio
HN21C1316
BACK